Quarterly report pursuant to Section 13 or 15(d)

Convertible Instruments and Accrued Interest (Tables)

v3.24.1.u1
Convertible Instruments and Accrued Interest (Tables)
9 Months Ended
Feb. 29, 2024
Convertible Instruments and Accrued Interest  
Schedule of information on dividends of convertible preferred stock

February 29, 2024

May 31, 2023

(in thousands except conversion rate)

    

Series B

    

Series C

    

Series D

    

Series B

    

Series C

    

Series D

Shares of preferred stock outstanding

19

6

9

19

6

9

Common stock conversion rate

10:1

2,000:1

1,250:1

10:1

2,000:1

1,250:1

Total shares of common stock if converted

190

12,670

10,565

190

12,670

10,565

Undeclared dividends

$

18

$

$

$

15

$

$

Accrued dividends

$

$

2,976

$

3,442

$

$

2,500

$

2,808

Total shares of common stock if dividends converted

36

5,952

6,884

30

5,000

5,616

Schedule of outstanding balances of convertible notes

February 29, 2024

May 31, 2023

(in thousands)

    

April 2, 2021 Note

    

April 23, 2021 Note

    

Total

    

April 2, 2021 Note

    

April 23, 2021 Note

Placement Agent Notes

Total

Convertible notes payable outstanding principal

$

2,831

$

27,869

$

30,700

$

6,081

$

29,369

$

1,000

$

36,450

Less: Unamortized debt discount and issuance costs

(58)

(473)

(531)

(211)

(822)

(286)

(1,319)

Convertible notes payable, net

2,773

27,396

30,169

5,870

28,547

714

35,131

Accrued interest on convertible notes

4,446

9,634

14,080

3,804

6,789

5

10,598

Outstanding convertible notes payable, net and accrued interest

$

7,219

$

37,030

$

44,249

$

9,674

$

35,336

$

719

$

45,729

Schedule of reconciliation of changes to outstanding balance of convertible notes

(in thousands)

April 2, 2021 Note

April 23, 2021 Note

Placement Agent Notes

Short-Term Notes

Total

Outstanding balance at May 31, 2023

$

9,674

$

35,336

$

719

$

$

45,729

Consideration received

975

698

1,673

Amortization of issuance discount and costs

153

349

583

302

1,387

Interest expense

642

2,845

18

7

3,512

Fair market value of shares and warrants exchanged for repayment

(4,737)

(1,826)

(4,379)

(2,558)

(13,500)

Difference between market value of
common shares and reduction of principal

1,487

326

2,084

1,551

5,448

Outstanding balance at February 29, 2024

$

7,219

$

37,030

$

$

$

44,249

Summary of outstanding convertible notes

February 29, 2024

    

April 2, 2021 Note

    

April 23, 2021 Note

Interest rate per annum

10

%

10

%

Conversion price per share upon five trading days' notice

$

10.00

$

10.00

Party that controls the conversion rights

Investor

Investor

Maturity date

April 5, 2025

April 23, 2025

Security interest

All Company assets excluding intellectual property